Use of MRI as an outcome measure in clinical trials in RA

被引：0
|
作者：
Annette H. M. van der Helm–van Mil
机构：
[1] Leiden University Medical Centre,Department of Rheumatology
来源：
Nature Reviews Rheumatology | 2012年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Following a decade of substantial improvements in sensitivity and usability, MRI is increasingly used to assess primary outcomes of therapeutic trials in rheumatoid arthritis (RA). In the wake of an MRI-based evaluation of treatment efficacy, what lessons are emerging about the clinical value of this technique for patients with RA?
引用
收藏
页码：643 / 644
页数：1
相关论文
共 50 条
  • [41] The use of MRI in early RA
    McQueen, F. M.
    RHEUMATOLOGY, 2008, 47 (11) : 1597 - 1599
  • [42] Use of outcome measures in pulmonary hypertension clinical trials
    Parikh, Kishan S.
    Rajagopal, Sudarshan
    Arges, Kristine
    Ahmad, Tariq
    Sivak, Joseph
    Kaul, Prashant
    Shah, Svati H.
    Tapson, Victor
    Velazquez, Eric J.
    Douglas, Pamela S.
    Samad, Zainab
    AMERICAN HEART JOURNAL, 2015, 170 (03) : 419 - +
  • [43] GD03 Identifying core outcome domains and development of a cutaneous leishmaniasis core outcome measure for use in clinical practice and trials
    Senarathne, Sujai
    Ranasinghe, Shalindra
    Kahawita, Indira
    Somaratne, Vijani
    Wickramasinghe, Amila
    Parkash, Vivak
    Lacey, Charles
    Kaye, Paul
    Layton, Alison
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [44] Use of surrogate endpoints vs. clinical outcome trials for registration trials
    Calvo, G.
    Suarez, M. L.
    Ruiz, M.
    PROCEEDINGS OF THE 8TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, : 5 - +
  • [45] A TECHNIQUE FOR POOLING OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS (RA) CLINICAL-TRIALS
    FORTIN, PR
    LEW, RA
    SPERLING, RI
    BECKETT, LA
    WRIGHT, EA
    LIANG, MH
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S195 - S195
  • [46] A TECHNIQUE FOR POOLING OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS (RA) CLINICAL-TRIALS
    FORTIN, PR
    LEW, RA
    SPERLING, RI
    BECKETT, LA
    WRIGHT, EA
    LIANG, MH
    ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : R40 - R40
  • [47] Guidance on the use of MRI for treatment planning in radiotherapy clinical trials
    Johnstone, Robert, I
    Guerrero-Urbano, Teresa
    Michaelidou, Andriana
    Greener, Tony
    Miles, Elizabeth
    Eaton, David
    Thomas, Christopher
    BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1105):
  • [48] Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials
    Panlilio, Leigh V.
    Stull, Samuel W.
    Bertz, Jeremiah W.
    Burgess-Hull, Albert J.
    Kowalczyk, William J.
    Phillips, Karran A.
    Epstein, David H.
    Preston, Kenzie L.
    PSYCHOPHARMACOLOGY, 2020, 237 (11) : 3369 - 3381
  • [49] USING 'DEAD OR DEPENDENT' AS AN OUTCOME MEASURE IN PARKINSON'S DISEASE CLINICAL TRIALS
    McGhee, David
    Parker, Alexander
    Fielding, Shona
    Counsell, Carl
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [50] Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials
    Saver, JL
    Johnston, KC
    Homer, D
    Wityk, R
    Koroshetz, W
    Truskowski, LL
    Haley, EC
    STROKE, 1999, 30 (02) : 293 - 298
12345